U.K.-based pharmaceutical company GlaxoSmithKline has signed an agreement to set up a joint venture with Chinese vaccine maker Jiangsu Walvax Biotech Co, sources reported on Tuesday. The joint venture will produce vaccines for children at a new facility to be built by GSK. GSK will initially invest US$32 million...
GlaxoSmithKline and Idenix Pharmaceuticals, Inc. announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899...
There will be major changes in the global pharmaceutical market and key changes in the top ten company list by 2012, says a new report from URCH Publishing, provider of pharmaceutical industry business information...
Philadelphia, September 9, 2009 鈥� GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological...
* Glaxo CEO sees Benlysta as "very major" product * Says will contribute meaningfully to bottom line NEW YORK, Nov 12 - GlaxoSmithKline Plc said on Thursday it expects its experimental lupus drug Benlysta to...
NEW YORK, Nov 12 - GlaxoSmithKline Plc <GSK.L> does not expect profit margins to slip substantially, despite an aggressive drive to diversify into areas such as consumer health and emerging markets, it chief executive said...
* ViiV Healthcare launched, pooling Glaxo and Pfizer drugs * CEO hopes to overtake Gilead, sees Selzentry as key driver LONDON, Nov 3 - GlaxoSmithKline, working alongside Pfizer in an unusual collaboration, aims to regain...
* Glaxo has yet to get FDA approval for vaccine * Senator asked why HHS made promises * Novartis, CSL working to improve production (Adds CDC comment paragraphs 11-13) WASHINGTON, Oct 27 - GlaxoSmithKline has...
* Glaxo has yet to get FDA approval for vaccine * Senator asked why HHS made promises * Novartis, CSL working to improve production WASHINGTON, Oct 27 - GlaxoSmithKline has yet to get U.S. government...
* Vaccine currently approved as two doses in children * Glaxo says 150,000 people have received vaccine so far (Adds further details, background) LONDON, Oct 23 - Britain's GlaxoSmithKline has shown that its H1N1 vaccine...